NeoTIL in Advanced Solid Tumors

NCT04643574 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

BIOLOGICAL: NeoTIL
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
RADIATION: Radiotherapy

Sponsor

Centre Hospitalier Universitaire Vaudois